THREE CUTTING EDGE DEVICES
The NovaCross™ is Nitiloop’s first-generation product. It recently completed a pivotal study and received FDA and CE clearance. The NovaCross™ consists of a nitinol scaffold, that while deployed, supports and centers a standard guidewire. When the scaffold is closed, the microcatheter can be further advanced.
The NovaCross™ Xtreme is Nitiloop’s flagship product. It is composed of a nitinol scaffold that while deployed supports both the guidewire and a crossing microcatheter that advances independently. The NovaCross™ Xtreme is FDA approved.
The NovaCross™ Below-the-Knee (BTK) is a modified version of the NovaCross™ Xtreme designed to reach the lower limbs in an antegrade or contra-lateral approach. The NovaCross™ BTK is CE approved.
NITILOOP'S PRODUCT LINE
Dr. William Nicholson
York, PA, USA
The NovaCross™ is a significant new addition to our CTO toolbox for tackling lesions. It improves our antegrade success rate while minimizing the risk of perforation. The device is simple and safe and can be easily adopted by either high-volume or low-volume cath lab clinicians.
Dr. Simon Walsh,
Belfast Trust Hospital
The NovaCross™ device has now completed evaluation in first-in-human and a pivotal FDA approval trial. The data confirm that the device is safe and efficacious, facilitating proximal cap crossing and success with antegrade wiring in complex lesions. The NovaCross™ gives added support for wiring and does not require added training for physician use.